Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Omega Diagnostics Reports CE-Mark Of Mologic Covid-19 Test

Thu, 03rd Sep 2020 18:15

Omega Diagnostics Group PLC - medical diagnostics company - CE-Marks Mologic Ltd's lateral flow antibody test for Covid-19 for sale under Omega's Visitect brand. The Mologic lateral flow antibody test is a point-of-care test that differentiates itself by testing for three antibodies, picking up positive patients at an earlier stage than most other tests. Omega said it will be the legal manufacturer of the test and will be able to manufacture up to 100,000 tests per week initially out of its Alva facility in Scotland.

Current stock price: 57.00 pence

Year-to-date change: quadrupled

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
6 Sep 2023 16:40

TRADING UPDATES: Solid State sees strong orders in security & defence

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

30 Aug 2023 15:44

UK shareholder meetings calendar - next 7 days

22 Aug 2023 10:41

Omega Diagnostics finance director steps down with immediate effect

(Alliance News) - Omega Diagnostics Group PLC on Tuesday said that Group Finance Director Chris Lea has stepped down with immediate effect, as he is b...

3 Aug 2023 14:08

Omega Diagnostics says revenue and loss hurt by operational issues

(Alliance News) - Omega Diagnostics Group PLC on Thursday said its annual loss widened as operational difficulties caused its revenue to plunge.

27 Jul 2023 15:40

UK earnings, trading statements calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.